Subscribe to RSS
DOI: 10.1055/a-2703-4537
Cryptogenic Organizing Pneumonia
Authors

Abstract
Cryptogenic organizing pneumonia (COP), formerly called bronchiolitis obliterans organizing pneumonia (BOOP), was first described in the 1980s and is classified as a rare idiopathic interstitial pneumonia (IIP). COP classically presents in a subacute fashion following a flu-like illness with fever, non-productive cough, and fatigue. Imaging often reveals diffuse, bilateral, peribronchovascular and peripheral, consolidative and ground-glass opacities although various imaging subtypes also exist. Physical examination may be normal or reveal inspiratory crackles. Hypoxemia, when present, is commonly identified with exertion but can also occur at rest. Diagnostic evaluation relies on excluding secondary causes of organizing pneumonia and includes a thorough history including medications, exposures, and signs or symptoms of underlying rheumatologic disease. Invasive diagnostic testing including tissue sampling allows for histopathologic confirmation of COP while excluding secondary causes including infection and malignancy. Although video-assisted thoracoscopic surgery (VATS) lung biopsy is often the preferred method of obtaining sufficient tissue, less invasive means may be employed based on patient-specific factors. A defining feature of COP is steroid-responsiveness, and most experts recommend prolonged corticosteroid courses (6–12 months). Response to corticosteroids and prognosis are typically excellent. Relapse rates range from 25 to 50% and occur most often during steroid taper or complete withdrawal necessitating additional therapy. Steroid-sparing immunosuppression may be used in select circumstances. Further study is needed to define optimal corticosteroid dose and duration.
Keywords
cryptogenic organizing pneumonia (COP) - organizing pneumonia (OP) - idiopathic interstitial pneumonia (IIP) - bronchiolitis obliterans organizing pneumonia (BOOP) - interstitial lung disease (ILD)Publication History
Received: 15 August 2025
Accepted: 16 September 2025
Accepted Manuscript online:
18 September 2025
Article published online:
23 October 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Davison AG, Heard BE, McAllister WA, Turner-Warwick ME. Cryptogenic organizing pneumonitis. Q J Med 1983; 52 (207) 382-394
- 2 Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312 (03) 152-158
- 3 American Thoracic Society, European Respiratory Society. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165 (02) 277-304
- 4 Gudmundsson G, Sveinsson O, Isaksson HJ, Jonsson S, Frodadottir H, Aspelund T. Epidemiology of organising pneumonia in Iceland. Thorax 2006; 61 (09) 805-808
- 5 Han SK, Yim JJ, Lee JH. et al. Bronchiolitis obliterans organizing pneumonia in Korea. Respirology 1998; 3 (03) 187-191
- 6 Barroso E, Hernandez L, Gil J, Garcia R, Aranda I, Romero S. Idiopathic organizing pneumonia: a relapsing disease. 19 years of experience in a hospital setting. Respiration 2007; 74 (06) 624-631
- 7 Torrealba JR, Fisher S, Kanne JP. et al. Pathology-radiology correlation of common and uncommon computed tomographic patterns of organizing pneumonia. Hum Pathol 2018; 71: 30-40
- 8 King Jr TE. BOOP: an important cause of migratory pulmonary infiltrates?. Eur Respir J 1995; 8 (02) 193-195
- 9 Davidsen JR, Madsen HD, Laursen CB. Reversed halo sign in cryptogenic organising pneumonia. BMJ Case Rep 2016; 2016: bcr2015213779
- 10 Kim SJ, Lee KS, Ryu YH. et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol 2003; 180 (05) 1251-1254
- 11 Jara-Palomares L, Gomez-Izquierdo L, Gonzalez-Vergara D. et al. Utility of high-resolution computed tomography and BAL in cryptogenic organizing pneumonia. Respir Med 2010; 104 (11) 1706-1711
- 12 Lee JS, Lynch DA, Sharma S, Brown KK, Müller NL. Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J Comput Assist Tomogr 2003; 27 (02) 260-265
- 13 Poletti V, Cazzato S, Minicuci N, Zompatori M, Burzi M, Schiattone ML. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 1996; 9 (12) 2513-2516
- 14 Miao L, Wang Y, Li Y. et al. Lesion with morphologic feature of organizing pneumonia (OP) in CT-guided lung biopsy samples for diagnosis of bronchiolitis obliterans organizing pneumonia (BOOP): a retrospective study of 134 cases in a single center. J Thorac Dis 2014; 6 (09) 1251-1260
- 15 Shimoda M, Tanaka Y, Morimoto K, Yoshimori K, Ohta K. Spontaneous resolution of cryptogenic organizing pneumonia: observational study. Medicine (Baltimore) 2023; 102 (27) e34277
- 16 King Jr TE, Lee JS. Cryptogenic organizing pneumonia. N Engl J Med 2022; 386 (11) 1058-1069
- 17 Zhou Y, Wang L, Huang M. et al. A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia. Chron Respir Dis 2019; 16: 1479973119853829
- 18 Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM“O”P). Am J Respir Crit Care Med 2000; 162 (2 Pt 1): 571-577
- 19 Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M. et al. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest 2011; 139 (04) 893-900
- 20 Matsuno O, Okubo F, Masutomo K. et al. Elevated concentrations of soluble IL-2 receptor in both bronchoalveolar lavage fluid and serum in a patient with BOOP. Tohoku J Exp Med 2003; 201 (01) 61-65
- 21 Radzikowska E, Roży A, Jagus P. et al. Clarithromycin decreases IL-6 concentration in serum and BAL fluid in patients with cryptogenic organizing pneumonia. Adv Clin Exp Med 2016; 25 (05) 871-878
- 22 Pathak V, Kuhn JM, Durham C, Funkhouser WK, Henke DC. Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. Ann Am Thorac Soc 2014; 11 (01) 87-91
- 23 Aslam W, Perez-Guerra F, Jebakumar D, Culver DA, Ghamande S. Acute fibrinous organising pneumonia presenting as a cavitary lung lesion and treatment response to azithromycin. BMJ Case Rep 2019; 12 (08) e230868
- 24 Stover DE, Mangino D. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia?. Chest 2005; 128 (05) 3611-3617
- 25 Laszlo A, Espolio Y, Auckenthaler A, Michel JP, Janssens JP. Azathioprine and low-dose corticosteroids for the treatment of cryptogenic organizing pneumonia in an older patient. J Am Geriatr Soc 2003; 51 (03) 433-434
- 26 Bhatti S, Hakeem A, Torrealba J, McMahon JP, Meyer KC. Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids. Respir Med 2009; 103 (11) 1764-1767
- 27 Paul C, Lin-Shaw A, Joseph M, Kwan K, Sergiacomi G, Mura M. Successful treatment of fibrosing organising pneumonia causing respiratory failure with mycophenolic acid. Respiration 2016; 92 (04) 279-282
- 28 Dimala CA, Patel U, Lloyd B. et al. A case report of steroid-resistant cryptogenic organizing pneumonia managed with intravenous immunoglobulins. Case Rep Pulmonol 2021; 2021: 9343491
- 29 Koinuma D, Miki M, Ebina M. et al. Successful treatment of a case with rapidly progressive bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern Med 2002; 41 (01) 26-29
- 30 Purcell IF, Bourke SJ, Marshall SM. Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia. Respir Med 1997; 91 (03) 175-177
- 31 Shitenberg D, Fruchter O, Fridel L, Kramer MR. Successful rituximab therapy in steroid-resistant, cryptogenic organizing pneumonia: a case series. Respiration 2015; 90 (02) 155-159
- 32 Yousem SA. Cicatricial variant of cryptogenic organizing pneumonia. Hum Pathol 2017; 64: 76-82
- 33 Dogan E, Tapan U, Tapan OO, Togan T, Çelik OI. Idiopathic focal organizing pneumonia mimicking malignancy. Pan Afr Med J 2020; 36: 256
- 34 Maldonado F, Daniels CE, Hoffman EA, Yi ES, Ryu JH. Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest 2007; 132 (05) 1579-1583
- 35 Melloni G, Cremona G, Bandiera A. et al. Localized organizing pneumonia: report of 21 cases. Ann Thorac Surg 2007; 83 (06) 1946-1951
- 36 Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002; 126 (09) 1064-1070
- 37 Xu XY, Chen F, Chen C, Sun HM, Zhao BL. Acute fibrinous and organizing pneumonia: a case report and literature review. Exp Ther Med 2016; 12 (06) 3958-3962
- 38 Onishi Y, Kawamura T, Higashino T, Mimura R, Tsukamoto H, Sasaki S. Clinical features of acute fibrinous and organizing pneumonia: an early histologic pattern of various acute inflammatory lung diseases. PLoS One 2021; 16 (04) e0249300
- 39 Kim MC, Kim YW, Kwon BS. et al. Clinical features and long-term prognosis of acute fibrinous and organizing pneumonia histologically confirmed by surgical lung biopsy. BMC Pulm Med 2022; 22 (01) 56
- 40 Lee JH, Yum HK, Jamous F. et al. Diagnostic procedures and clinico-radiological findings of acute fibrinous and organizing pneumonia: a systematic review and pooled analysis. Eur Radiol 2021; 31 (10) 7283-7294
- 41 Radzikowska E, Fijolek J. Update on cryptogenic organizing pneumonia. Front Med (Lausanne) 2023; 10: 1146782
- 42 Raghu G, Meyer KC. Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease. Eur Respir Rev 2021; 30 (161) 210094
- 43 Cottin V, Cordier JF. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med 2012; 33 (05) 462-475